The global short-acting beta-agonists market, crucial medications for treating asthma and COPD, is poised for substantial ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...

Request To Download Free Sample of This Strategic Report @ The publisher has been closely monitoring the various markets in Saudi Arabia Respiratory Disease Vaccine Market. This report provides a ...

Liquidia LQDA is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what ...

"Our company has continued on its strong growth trajectory in the first nine months of 2024. Total Revenue and Core EPS were up 21% and 27% respectively in the third quarter, reflecting the increasing ...

DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

Request To Download Free Sample of This Strategic Report @ The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing ...

Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

Collective Audience, Inc. , a leading innovator of audience-based performance advertising and media for the open web, has appointed Gerald (Gerry) Garcia as chief financial officer.AdTech Veteran, ...

On average each study participant was receiving primary care for three chronic medical conditions such as diabetes, heart disease, hypertension or chronic obstructive pulmonary disease and they were ...